Today: 9 April 2026
Palantir stock steadies after UBS upgrade, Rosenblatt buy call as AI jitters bite
27 February 2026
2 mins read

Palantir stock steadies after UBS upgrade, Rosenblatt buy call as AI jitters bite

New York, February 27, 2026, 11:04 EST — Regular session

  • Palantir shares picked up in morning trade, boosted by a round of bullish analyst calls.
  • UBS bumped Palantir up to “Buy”, while Rosenblatt started coverage on the stock with its own “Buy” rating.
  • Risk appetite stayed thin as a wider tech selloff, fueled by concerns over AI and inflation, weighed on sentiment.

Palantir Technologies Inc. picked up 0.6% to $136.74 late Friday morning, getting a boost after UBS raised its rating and Rosenblatt kicked off coverage with a buy call. The gains came despite weakness in the broader market. Palantir remains down roughly 23% since the year’s open. MarketScreener

Timing is a factor. Wall Street’s major indexes slid, with investors digesting hotter inflation numbers and ramping up the AI-versus-profits debate — and what that might mean for jobs. According to Reuters, the Nasdaq and S&P 500 were both heading for their sharpest monthly loss since March 2025. “There are a lot of questions around AI,” one UBS Global Wealth Management strategist said, adding that it’s also about the “future of tech.” Reuters

Palantir’s name pops up whenever the AI software rally comes under scrutiny. The company’s seen as a standout among AI winners, but that also puts it in the crosshairs when investors pull back from pricey growth stocks.

UBS bumped Palantir up to “Buy” from “Neutral,” holding steady with a $180 price target. The bank noted shares are sitting about 35% below their high, calling the drop “a very compelling entry point.” In a note, Karl Keirstead and his team pointed out that, trading at “50x our 2027” free-cash-flow estimates—free cash flow meaning cash after expenses and investment—the stock looks “very attractive” compared with their view for solid growth and mid-50% margins. Investing.com

Rosenblatt jumped in with fresh coverage, slapping a “buy” on Palantir and setting a $150 target. The firm called Palantir a “market-disrupting AI software leader.” Investing.com

Just weeks after Palantir’s previous earnings release, upbeat commentary is rolling in. The company’s fourth-quarter 2025 numbers and its 2026 outlook had already outpaced much of Wall Street: Palantir laid out a full-year 2026 revenue target between $7.18 billion and $7.20 billion, with first-quarter revenue pegged at $1.532 billion to $1.536 billion. Executives also spotlighted significant momentum in the U.S. commercial segment, crediting its Artificial Intelligence Platform. Palantir Investors

Upgrades aside, the stock is still a valuation story, and these days, the market isn’t cutting much slack. Higher-for-longer rates, if inflation sticks around, usually mean investors won’t pay up for growth that’s years out — software names are often hit first by that kind of multiple squeeze.

Traders are eyeing Palantir to see if it keeps turning AI pilots into sizable, recurring deals—particularly if the big cloud and data-platform players ramp up their competitive push.

Investors now turn to the company’s next earnings report, which is expected near May 4, based on Yahoo Finance estimates. They’re set to scrutinize updates on demand, margins, and guidance for the full year. finance.yahoo.com

Stock Market Today

  • QuidelOrtho (QDEL) Shares Slide 23% in a Month Amid Valuation Debate
    April 8, 2026, 9:37 PM EDT. QuidelOrtho (QDEL) shares slipped 22.86% over the past month to $15.32, despite a 2.27% gain on the latest trading day. The stock's 1-year total shareholder return tallies 46.90%, showing past momentum is fading. Analysts flag a sharp valuation gap: market price trails the $34.67 fair value estimate by over 80%, spotlighting risks in execution and reimbursement trends. Expansion into global markets like Latin America and Asia Pacific offers growth potential, underpinned by demand for early detection and immunoassay technologies. But COVID testing normalization and product discontinuations weigh on revenue diversity and margins. Investors should weigh these mixed signals carefully and consider broadening healthcare AI exposure rather than concentrating on one stock story.

Latest article

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

8 April 2026
Zevenbergen Capital increased its Alphabet Class A share holdings by 27.4% in Q4, while Lombard Odier and Empirical Wealth Management reduced their Class C positions, according to April 7 filings. Alphabet will report first-quarter results on April 29. GOOG and GOOGL traded near $304 before Wednesday’s U.S. open. The filings reflect holdings as of December 31 and may not show current positions.
Lumentum stock snaps back after 6% slide as traders eye next catalyst
Previous Story

Lumentum stock snaps back after 6% slide as traders eye next catalyst

Oracle (ORCL) stock price drops as AI-spending doubts bite again, with March earnings next test
Next Story

Oracle (ORCL) stock price drops as AI-spending doubts bite again, with March earnings next test

Go toTop